Pharma: Page 47
-
PharmaVoice Team/PharmaVoice
Talent Pool
Biopharma Pool David Allsop Amicus Therapeutics Appoints Senior VP, International Amicus Therapeutics, a biopharmaceutical company at the forefront of therapies for rare and orphan diseases, has appointed David Allsop as senior VP, international. He is responsible for Amicus’ international organi...
By PharmaVoice Team • June 1, 2015 -
PharmaVoice Team/PharmaVoice
Last Word
Pharma’s Health Mission Novo Nordisk North America President Jesper Hoiland talks about the responsibility pharmaceutical companies have to society and the larger impact they can have on health and the environment. PV: Why should pharmaceutical companies become involved in social issues? Hoiland...
By Jesper Hollad • June 1, 2015 -
Explore the Trendline➔
Stock via Getty Images
TrendlineCommercialization, marketing and social media
As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Rare Diseases: Research, Development, and Commercialization
In the past few years, significant progress has been made in rare diseases; in 2014, orphan drugs constituted 17 of the 41 new molecular entities approved by the Food and Drug Administration. An average of 140 drugs have been designated as orphan drugs by the FDA each year over the past decade, c...
By Denise Myshko • June 1, 2015 -
PharmaVoice Team/PharmaVoice
Poland: Eastern Europe's Leading Light
With a population of 38 million people and a healthy, growing economy, Poland is an attractive market for the pharma industry. This is bolstered by the fact that Poland is a member of the European Union, providing it with stability and a predictable regulatory environment. Poland underwent many p...
By Kim Ribbink • June 1, 2015 -
PharmaVoice Team/PharmaVoice
What's New
Turing Pharmaceuticals New Drug Company Launched Trending now: Experienced team comes together to focus on treating unmet medical needs. Turing Pharmaceuticals, a new pharmaceutical company, launched with news of three acquisitions for its commercial operations and development pipeline. New York-...
By PharmaVoice Team • May 1, 2015 -
PharmaVoice Team/PharmaVoice
Pharma Trax
Cancer Care in America: A Shifting Landscape Trending now: Amid growing patient demand and administrative burden, there are stresses on the oncology care system. The U.S. cancer care system faces tremendous turbulence while dealing with growing numbers of cancer patients and survivors, mounting ...
By PharmaVoice Team • May 1, 2015 -
PharmaVoice Team/PharmaVoice
Talent Pool
Biopharma Pool Steven Ertel Dr. Matthew Sherman Acceleron Pharma Announces Executive Appointments and Promotions Acceleron Pharma, a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic candidates that regulate cellular growth...
By PharmaVoice Team • May 1, 2015 -
PharmaVoice Team/PharmaVoice
2015 HBA Luminaries
The Importance of Mentoring and Sponsorship Emily Lightfoot. AmerisourceBergen. Relationships with mentors have been the key to my career success. Having an advocate and coach to help me plan my career, discover my strengths, and identify opportunities has helped me develop confidence to take on ...
By Taren Grom • May 1, 2015 -
PharmaVoice Team/PharmaVoice
Talent Pool
Biotechnology Pool Tony Hunt Repligen Names CEO Repligen, a life-sciences company focused on the development and commercialization of high-value consumable products used in the process of manufacturing biological drugs, has appointed Tony Hunt as CEO. Mr. Hunt, currently Repligen’s chief operatin...
By PharmaVoice Team • March 1, 2015 -
PharmaVoice Team/PharmaVoice
Talent Pool
Executive appointments and promotions in the healthcare industry Pharma Pool Dr. Julie Gerberding Merck Strengthens Executive Team Merck has named Julie Gerberding, M.D., as executive VP for strategic communications, global public policy and population health. In this newly created executive comm...
By PharmaVoice Team • Feb. 1, 2015 -
PharmaVoice Team/PharmaVoice
Last Word
Addressing the Needs of THOSE WITH RARE DISEASES Peter Saltonstall, President and CEO of the National Organization for Rare Disorders (NORD), talks about recent orphan drug approvals. PV: 2014 was a record year for orphan drug approvals. What are your predictions for the orphan drug space for 201...
By Peter Saltonstall • Feb. 1, 2015 -
PharmaVoice Team/PharmaVoice
Talent Pool
Executive appointments and promotions in the healthcare industry Pharma Pool Stephen Aselage Retrophin Appoints CEO Retrophin has appointed Stephen Aselage as CEO; he has served as the company’s interim CEO since Sept. 30, 2014. Mr. Aselage has more than 30 years of pharmaceutical and biotechnolo...
By PharmaVoice Team • Jan. 1, 2015 -
PharmaVoice Team/PharmaVoice
R&D Crowdsourcing: Crowdsourcing in Pharma
Companies are looking at nontraditional ways of collaborating to access new insights that could lead to innovative therapies. There is a growing movement within the industry toward open access and crowdsourcing scientific information to accelerate research and development. This open environment r...
By Denise Myshko • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: E-Solutions: Power Surge
E-Solutions ranging from mobile advances to EMR technologies are expected to reframe the patient model. Notably, the most encouraging news on mobile and quantified health is the recent announcement and launch of the HealthKit platform and the mobile app Health by Apple. HealthKit allows devices a...
By Taren Grom • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
UpFront
INDUSTRY at Large Bayer Helps Students Pursue Science Bayer Corp. presented a $100,000 two-year grant from the Bayer USA Foundation to Students 2 Science (S2S), an innovative STEM education organization that introduces elementary, middle, and high-school students from northern and central New Je...
By Denise Myshko • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
StayinFront Partners With MedPro Systems Trending Now: Life-sciences CRM software release improves efficiency and in-field PDMA compliance by providing sales reps with real-time mobile access to 14 million records. StayinFront and MedPro Systems have partnered to allow pharmaceutical field repre...
By Denise Myshko • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
Year in Preview: On the Horizon: Looking Ahead…
Experts from across all sectors of the industry provide their input on the trends in 2015 that will have the biggest impact on the industry, and how they will shape the future of healthcare. For this year’s special Year in Preview issue we took a slightly different tact than in years past. We are...
By Taren Grom • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
Talent Pool
Biotech Pool Dr. Annalisa Jenkins Dimension Therapeutics Names CEO Dimension Therapeutics, a gene therapy company focused on developing novel treatments for rare diseases, has apppointed Annalisa Jenkins, MBBS, MRCP, CEO. Dr. Jenkins succeeds interim CEO Thomas Beck. Dr. Jenkins brings to Dimensi...
By Ann Grey • Nov. 15, 2014 -
PharmaVoice Team/PharmaVoice
Electronic Health Record: A Focus On Patient Benefits
When we think of the positive impact of electronic health record (EHR) adoption, we often focus on the increased efficiency of the medical practice or additional convenience for healthcare providers (HCPs). We do not often associate those benefits with our most important target: the patient. Curr...
By Eugene Lee • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
Embracing Co-Creation to Better Connect
Many patient and caregiver campaigns fail to resonate with their intended audiences. Innovative collaboration methods and co-creation with patients and caregivers can add authenticity to communications and elevate brands. Do you remember the telephone game when you were a kid? One person starts t...
By Dan Bobear • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
Transdermal Delivery: Winning Patient Preference
The pharma landscape continues to be crowded and competitive, with more emphasis than ever before on delivering improved patient outcomes at a competitive price. In light of this, pharmaceutical companies must not only deliver products that effectively treat patients’ problems, but also prioritiz...
By Ingrid Blair • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Patient Solutions
As healthcare systems begin to pay for outcomes rather than products, patient-centric solutions and services will play a key role in the race to capture value. From wearables to improved drug delivery devices, from apps to EHR platforms, from patient trackers to packaging, the number of solution...
By Taren Grom • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
Vested Outsourcing Imperative
Managing the Talent Supply Chain Large life sciences companies today face many challenges in acquiring and managing talent to meet their business imperatives. The first decision to be made is always the same, whether the workforce contains full-time employees, contingent workers, independent cont...
By Kevin D. Duffy • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Supply Chain: Talent Management: A Different Supply Chain Issue
A sound workforce strategy furthers a company’s business agenda and generates results. When the topic of supply chain management is discussed, the conversation typically is about manufacturing and distribution issues. But today one of the most pressing challenges facing CEOs is the talent supply ...
By Taren Grom • Sept. 27, 2014 -
PharmaVoice Team/PharmaVoice
Colombia Emerges as an Attractive Pharma Market
With a growing interest in attracting R&D and continual economic growth, Colombia is seen as an attractive market for pharmaceutical companies. The Republic of Colombia is evolving from an emerging economy, having enjoyed an economic turnaround since 2000, when it was perceived by economists ...
By Kim Ribbink • Sept. 27, 2014
Previous
